Latest filing published 10 Sept 2024 for 아이빔테크놀로지.
의약바이오컨버젼스연구단: trading record in brief
All filings by 의약바이오컨버젼스연구단 on record concern 아이빔테크놀로지. The record holds 2 filings, for trades running from 6 August 2024 to 9 September 2024.
In open-market terms, that means 1 purchase on one side and 1 sale on the other. No amount is published for 2 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
On 10 September 2024 came the latest disclosure, an open-market sale in 아이빔테크놀로지. The last insider purchase was made public on 12 August 2024, 818 days ago. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 의약바이오컨버젼스연구단
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 51,674 sharesKRXDART:20240910000165
- 750,000 sharesKRXDART:20240812000531Canonical exit: 10 Nov 2024 (T+90)
2 of 2 declarations